Filgrastim biosimilar(Shandong Xinshidai Biotech)

非格司亭生物类似药（山东新时代）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar(Shandong Xinshidai Biotech)

Drug Alias Name非格司亭生物仿制药（山东新时代）rhG-CSF (Shandong Xinshidai Biotech)重组人粒细胞刺激因子（山东新时代）Recombinant human granulocyte macrophage colony stimulating factor (Shandong Xinshidai Biotech)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionImmunomodulatorsColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsImmune System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusNDA/BLA

Highest Status in ChinaNDA/BLA

Originator CompaniesLunan Pharmaceutical Group Co

China Registration ClassN/A

Develop Information

Active CompaniesLunan Pharmaceutical Group Co

Inactive CompaniesN/A

Active IndicationsImmune System Diseases

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02